NON-SMALL CELL LUNG CANCER STAGE III
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo may help more lung cancer patients get Life-Extending radiation
Disease control TerminatedThis study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy could shrink large stage III lung tumors enough to allow patients to then receive radiation therapy. The trial was stopped early after enrolling only 10 people, so results are limited. The…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Step counts may predict trouble during lung cancer therapy
Symptom relief TerminatedThis study tested whether monitoring daily step counts in people with stage III non-small cell lung cancer during chemoradiotherapy helps doctors provide better supportive care and reduce hospital stays or treatment delays. Only 3 participants were enrolled before the study was s…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE III
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 22, 2026 12:04 UTC